Renal Anemia
Conditions
Interventions
Pemoxatide Group:None
Sponsors
Anhui Medical University Affiliated Fuyang Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients must meet all of the following criteria: aged 18 years or older; on maintenance hemodialysis for more than 3 months; diagnosed with renal anemia with a relatively stable hemoglobin level between 90 and 120 g/L over the past 4 weeks; stable dosage of erythropoietin for at least 4 weeks; and voluntarily provide signed informed consent.
Exclusion criteria
Exclusion criteria: Patients will be excluded if they meet any of the following conditions: active bleeding or a history of blood transfusion within the past 3 months; uncontrolled severe hypertension or a major cardiovascular event within the past 6 months; active infection, malignancy, or severe hepatic disease; known hypersensitivity to Pemoxatide; or anticipated inability to complete the study follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coefficient of Variation of Hemoglobin;Average Monthly Frequency of Administration; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemoglobin Target Achievement Rate;Mean Hemoglobin Level;Iron Metabolism Parameters (Ferritin, TSAT);Treatment Satisfaction and Convenience Score; | — |
Countries
China
Contacts
Public ContactYan Liangliang
Anhui Medical University Affiliated Fuyang Hospital
Outcome results
None listed